Literature DB >> 14462996

Studies with radioactive gold.

J S LAWRENCE.   

Abstract

Keywords:  GOLD/therapy

Mesh：

Substances：

Year:  1961        PMID： 14462996      PMCID： PMC1007233          DOI： 10.1136/ard.20.4.341

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Serum antiplasmin and plasmin in rheumatoid arthritis.

Authors:  D P P THOMAS; J T DINGLE
Journal:  Ann Rheum Dis       Date:  1955-06       Impact factor: 19.103

2.  Distribution of sulfur-35- and gold-198-labeled gold thioglucose in mice.

Authors:  H A SWARTZ; J E CHRISTIAN; F N ANDREWS
Journal:  Am J Physiol       Date:  1960-07

3.  Some cation-binding properties of cartilage.

Authors:  J R DUNSTONE
Journal:  Biochem J       Date:  1959-07       Impact factor: 3.857

4.  Increasing the effectiveness of gold therapy in rheumatoid arthritis.

Authors:  R T SMITH; W P PEAK; K M KRON; I F HERMANN; R A DELTORO; M GOLDMAN
Journal:  J Am Med Assoc       Date:  1958-07-05

5.  [Rheumatologic comments on radioisotopes and radioactive colloidal gold in particular].

Authors:  A VERHAEGHE; R LEBEURRE
Journal:  Rev Rhum Mal Osteoartic       Date:  1954-02

6.  METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE.

Authors:  R H Freyberg; W D Block; S Levey
Journal:  J Clin Invest       Date:  1941-07       Impact factor: 14.808

7.  Gold Treatment in Rheumatoid Arthritis.

Authors:  T N Fraser
Journal:  Ann Rheum Dis       Date:  1945-06       Impact factor: 19.103

8.  Radioactive gold in filter paper electrophoresis patterns of plasma.

Authors:  N SIMON
Journal:  Science       Date:  1954-01-15       Impact factor: 47.728

9.  Studies on the inhibition of proteolytic enzymes by serum. III. Physiological aspects of variations in proteolytic inhibition. The concurrence of changes in fibrinogen concentration with changes in trypsin inhibition.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307
  9 in total
  18 in total

Review 1.  Clinical pharmacokinetics of oral and injectable gold compounds.

Authors:  K L Blocka; H E Paulus; D E Furst
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

Review 2.  The pharmacological consequences of the binding of anti-rheumatic drugs to plasma proteins in the treatment of rheumatoid arthritis.

Authors:  J N McArthur
Journal:  Agents Actions       Date:  1979-06

Review 3.  Monitoring gold plasma levels in rheumatoid arthritis.

Authors:  A Lorber
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

4.  Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.

Authors:  J D Jessop; R G Johns
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

5.  Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.

Authors:  A Lorber; C J Atkins; C C Chang; Y B Lee; J Starrs; R A Bovy
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

6.  Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis.

Authors:  F E Krusius; A Markkanen; P Peltola
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

7.  Influence of gold salts on adjuvant arthritis in the rat.

Authors:  J D Jessop; H L Currey
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

8.  Transport of gold in the body.

Authors:  E G McQueen; P W Dykes
Journal:  Ann Rheum Dis       Date:  1969-07       Impact factor: 19.103

Review 9.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

10.  Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.